RY

170.6

-0.64%↓

TD

94.22

-0.55%↓

BMO

129.87

-0.45%↓

BNS

73.71

-0.32%↓

CM

90.65

-0.92%↓

RY

170.6

-0.64%↓

TD

94.22

-0.55%↓

BMO

129.87

-0.45%↓

BNS

73.71

-0.32%↓

CM

90.65

-0.92%↓

RY

170.6

-0.64%↓

TD

94.22

-0.55%↓

BMO

129.87

-0.45%↓

BNS

73.71

-0.32%↓

CM

90.65

-0.92%↓

RY

170.6

-0.64%↓

TD

94.22

-0.55%↓

BMO

129.87

-0.45%↓

BNS

73.71

-0.32%↓

CM

90.65

-0.92%↓

RY

170.6

-0.64%↓

TD

94.22

-0.55%↓

BMO

129.87

-0.45%↓

BNS

73.71

-0.32%↓

CM

90.65

-0.92%↓

Search

Hercules Capital Inc

Fermé

SecteurFinance

18.82 0.27

Résumé

Variation du prix de l'action

24h

Actuel

Min

18.75

Max

18.87

Chiffres clés

By Trading Economics

Revenu

61M

119M

Ventes

89M

169M

P/E

Moyenne du Secteur

10.764

25.743

Rendement du dividende

8.56

Marge bénéficiaire

70.164

Employés

100

EBITDA

18M

120M

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+6.99% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

8.56%

3.67%

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

139M

3.4B

Ouverture précédente

18.55

Clôture précédente

18.82

Sentiment de l'Actualité

By Acuity

50%

50%

154 / 526 Classement par Finance

Score Technique

By Trading Central

Confiance

Neutral Evidence

Hercules Capital Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

31 déc. 2025, 22:20 UTC

Principaux Mouvements du Marché

Outlook Therapeutics Shares Fall After Another FDA Rejection of Macular Degeneration Drug

31 déc. 2025, 17:31 UTC

Principaux Mouvements du Marché

OwlTing Climbs on Launch of $10 Million Stock-Buyback Program

31 déc. 2025, 16:30 UTC

Principaux Mouvements du Marché

Trump Media Gains on Plan to Distribute Digital Tokens to Shareholders

31 déc. 2025, 15:19 UTC

Principaux Mouvements du Marché

Axsome Shares Climb on FDA Fast‑Track for Alzheimer's Drug, Backing for Narcolepsy Filing

31 déc. 2025, 15:17 UTC

Principaux Mouvements du Marché

Nike Shares Rise After CEO Hill Buys $1 Million of Shares

31 déc. 2025, 14:37 UTC

Principaux Mouvements du Marché

Corcept Shares Fall as FDA Requires More Evidence for Hypercortisolism Drug Application

31 déc. 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

31 déc. 2025, 21:13 UTC

Acquisitions, Fusions, Rachats

10 People to Watch in Wealth Management in 2026 -- Barrons.com

31 déc. 2025, 20:40 UTC

Market Talk

Dollar Posting Its Worst Year Since 2017 -- Market Talk

31 déc. 2025, 20:22 UTC

Market Talk

Oil Posts Loss in a Year Marked By Plentiful Supply -- Market Talk

31 déc. 2025, 19:50 UTC

Market Talk

U.S. Natural Gas Futures Sink on Weather Outlook -- Market Talk

31 déc. 2025, 19:31 UTC

Market Talk

Precious Metals Cap Off Record Runs -- Market Talk

31 déc. 2025, 18:50 UTC

Market Talk

Global Equities Roundup: Market Talk

31 déc. 2025, 18:50 UTC

Market Talk

Canadian Gold Miners Enjoy a Bumper Year in 2025 -- Market Talk

31 déc. 2025, 17:17 UTC

Market Talk

U.S. Natural Gas Inventories Fall Less Than Expected -- Market Talk

31 déc. 2025, 17:16 UTC

Principaux Mouvements du Marché

OwlTing Climbs on Launch of $10M Stock-Buyback Program

31 déc. 2025, 17:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

31 déc. 2025, 17:00 UTC

Acquisitions, Fusions, Rachats

Nvidia Is Getting Creative as Options to Use Its Cash Flood Narrow -- Heard on the Street -- WSJ

31 déc. 2025, 15:57 UTC

Acquisitions, Fusions, Rachats

Vanda Pharmaceuticals Shares Jump 30% on Motion Sickness Drug Approval -- Barrons.com

31 déc. 2025, 15:54 UTC

Market Talk

Layoff Data Supports Dollar at End of Losing Year -- Market Talk

31 déc. 2025, 15:02 UTC

Principaux Mouvements du Marché

Nike Shares Rise After CEO Hill Buys $1M of Shares

31 déc. 2025, 14:40 UTC

Acquisitions, Fusions, Rachats

Nike CEO Buys $1 Million of Stock as Insiders Bet on a Turnaround -- Barrons.com

31 déc. 2025, 14:20 UTC

Market Talk

Crude Futures On Track to End the Year With Losses -- Market Talk

31 déc. 2025, 13:46 UTC

Market Talk

U.S. Natural Gas Falls on Milder Weather Outlook -- Market Talk

31 déc. 2025, 13:01 UTC

Résultats
Acquisitions, Fusions, Rachats

Charles Schwab Is Back on Offense. Its Stock Is a Buy. -- Barrons.com

31 déc. 2025, 11:10 UTC

Market Talk

Copper Remains in Touching Distance of Record Highs -- Market Talk

31 déc. 2025, 10:46 UTC

Market Talk

Euro on Track For Strong Annual Performance -- Market Talk

31 déc. 2025, 10:25 UTC

Market Talk

European Gas Prices Rise But Remain on Track for Heavy Annual Loss -- Market Talk

31 déc. 2025, 10:23 UTC

Market Talk

Chinese Yuan Rises to 31-Month High Against Dollar as Policymakers -- Market Talk

31 déc. 2025, 09:33 UTC

Market Talk

Dollar Set For Worst Annual Performance Since 2017 -- Market Talk

Comparaison

Variation de prix

Hercules Capital Inc prévision

Objectif de Prix

By TipRanks

6.99% hausse

Prévisions sur 12 Mois

Moyen 20.04 USD  6.99%

Haut 24 USD

Bas 18 USD

Basé sur 7 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

7 ratings

6

Achat

1

Maintien

0

Vente

Score Technique

By Trading Central

17.41 / 17.93Support & Résistance

Court Terme

Neutral Evidence

Moyen Terme

Strong Bearish Evidence

Long Terme

Bearish Evidence

Sentiment

By Acuity

154 / 526Classement par Finance

Sentiment de l'Actualité

Neutral

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Moyen

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Hercules Capital Inc

Hercules Capital, Inc. is a business development company. The firm specializing in providing private equity, venture debt, and growth capital to privately held venture capital-backed companies at all stages of development from mid venture to expansion stage including select publicly listed companies and select special opportunity companies that require additional capital to fund acquisitions, recapitalizations and refinancing and established-stage companies. The firm provides growth capital financing solutions for capital extension; management buy-out and corporate spin-out financing solutions; company, asset specific, or intellectual property acquisition financing; convertible, subordinated and/or mezzanine loans; domestic and international corporate expansion; vendor financing; revenue acceleration by sales and marketing development, and manufacturing expansion. It provides asset-based financing with a focus on cash flow; accounts receivable facilities; equipment loans or leases; equipment acquisition; facilities build-out and/or expansion; working capital revolving lines of credit; inventory. The firm also provides bridge financing to IPO or mergers and acquisitions or technology acquisition; dividend recapitalizations and other sources of investor liquidity; cash flow financing to protect against share price volatility; competitor acquisition; pre-IPO financing for extra cash on the balance sheet; public company financing to continue asset growth and production capacity; short-term bridge financing; and strategic and intellectual property acquisition financings. It also focuses on customized financing solutions, emerging growth, mid venture, and late venture financing. The firm invests primarily in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The firm generally seeks to invest in companies that have been operating for at least six to 12 months prior to the date of their investment. It prefers to invest in technology, SaaS Finance, energy technology, sustainable
help-icon Live chat